Whether UroMap can be used to identify patients that need a biopsy from those that may not need one, in setting of BKVAN or rejection. Specifically, can UroMap be added as an additional test to get different, more specific information?
Not Available
Utility of UroMap as a biomarker for rejection in pediatric transplant recipients